Provided by: CHINA CHEMICAL & PHARMACEUTICAL CO., LTD.
SEQ_NO
3
Date of announcement
2022/03/08
Time of announcement
16:50:32
Subject
The Board of Directors approved the consolidated
financial reports of 2021.
Date of events
2022/03/08
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/03/08
2.Date of approval by the audit committee:2022/03/08
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):7,948,998
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):2,864,792
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):423,889
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):659,240
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):516,355
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):517,508
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):1.74
11.Total assets end of the period (thousand NTD):12,786,876
12.Total liabilities end of the period
(thousand NTD):4,998,406
13.Equity attributable to owners of parent end of the
period (thousand NTD):7,754,110
14.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
CCPC – China Chemical and Pharmaceutical Co. Ltd. published this content on 08 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 March 2022 09:00:09 UTC.
CHINA CHEMICAL & PHARMACEUTICAL CO., LTD. is a Taiwan-based company principally engaged in the manufacture and sales of pharmaceuticals. The products of the Company include pharmaceuticals for human, animal drugs, medical devices, daily products and nutritious food products. Pharmaceuticals for human include prescription drugs and patented medicines, among others. Medical equipment includes nursing liquid for contact lens, sphygmomanometers and manmade joints. Animal drugs include feedstuff additives and healthcare products for animals, among others. Daily products include toothpastes, shower liquid, facial masks and mouth rinses, among others. The Company operates businesses in Taiwan and Mainland China.